Cubist Systematic Strategies, LLC Zynerba Pharmaceuticals, Inc. Transaction History

Cubist Systematic Strategies, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.83 - $3.02 $34,770 - $57,380	-19,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.88 - $4.3 $49,320 - $73,637	-17,125 Reduced 47.4%	19,000 $55,000
Q3 2021 Nov 15, 2021	SELL	$3.72 - $5.35 $132,699 - $190,845	-35,672 Reduced 49.68%	36,125 $153,000
Q2 2021 Aug 16, 2021	BUY	$3.83 - $5.98 $219,826 - $343,228	57,396 Added 398.56%	71,797 $380,000
Q1 2021 May 17, 2021	BUY	$3.33 - $8.76 $47,955 - $126,152	14,401 New	14,401 $67,000
Q1 2020 May 15, 2020	SELL	$2.9 - $6.16 $83,285 - $176,909	-28,719 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$5.61 - $8.57 $98,820 - $150,960	17,615 Added 158.64%	28,719 $173,000
Q3 2019 Nov 14, 2019	BUY	$7.56 - $15.44 $83,946 - $171,445	11,104 New	11,104 $84,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.